6.1 Neonatal Glucose Homeostasis

6.1 Neonatal Glucose Homeostasis

Quick Answer: After cord clamping, the neonate must replace a continuous placental glucose infusion with glycogenolysis and gluconeogenesis. Treat symptomatic hypoglycemia at any confirmed low value. For asymptomatic at-risk infants, many units use operational cutoffs in the about 40-50 mg/dL range during the first hours. AAP and Pediatric Endocrine Society (PES) statements exist, and unit protocols vary. AACN does not publish an official milligram-per-deciliter cutoff. Give D10W 2 mL/kg, then start a glucose infusion. Typical starting glucose infusion rate (GIR) is 4-8 mg/kg/min; hyperinsulinism often needs more. Infant of a diabetic mother (IDM) hypoglycemia is ongoing fetal hyperinsulinism after birth.

The neonatal brain is a glucose-avid organ. In utero the fetus does not fast. Glucose crosses the placenta by facilitated diffusion, and fetal concentrations run about 70-80% of the simultaneous maternal value. Hepatic glycogen is laid down mainly in the third trimester, so a term infant arrives with a modest reserve and an extremely preterm infant arrives with almost none. When the cord is clamped, that infusion stops within seconds. Plasma glucose falls over the next one to two hours. Recovery depends on a coordinated endocrine switch: insulin should fall; glucagon, catecholamines, and cortisol should rise; glycogen should break down; gluconeogenesis should start; and fatty-acid oxidation should produce ketones as alternative fuel.

A brief nadir in a well term newborn who then feeds and recovers is not the same problem as a persistently low glucose in an insulin-driven or glycogen-depleted infant. Pathologic hypoglycemia is low glucose that threatens the brain, especially when ketones are also suppressed. OpenExamPrep provides independent CCRN Neonatal study material covering the endocrine patient problems listed on AACN Certification Corporation's current Neonatal CCRN Test Plan, including glucose homeostasis. This is not a substitute for your unit protocol or for a pediatric endocrinology consult when hypoglycemia persists.

Who needs surveillance

Screen and intervene early in infants with:

• Preterm or late-preterm gestation (limited glycogen, immature enzymes)
• Small-for-gestational-age or intrauterine growth restriction
• Large-for-gestational-age status, with or without a documented diabetic pregnancy
• Infant of a diabetic mother
• Perinatal hypoxia-ischemia, hypothermia, or suspected sepsis
• Polycythemia, which increases glucose utilization
• Syndromic risk for hyperinsulinism, including Beckwith-Wiedemann
• A family history or clinical hint of fatty-acid oxidation disease or another inborn error

Symptoms are neither sensitive nor specific. Jitteriness, lethargy, hypotonia, poor feeding, apnea, cyanosis, hypothermia, and seizures can all be glucose-related. Many hypoglycemic infants look well. Many jittery infants have a normal glucose. Check a value whenever the clinical picture is unexplained, and treat low glucose while you still evaluate sepsis, asphyxia, and metabolic disease. Point-of-care meters are convenient but imperfect at the extremes; plasma laboratory glucose is the confirmatory standard when a treatment decision sits close to a threshold.

Operational thresholds, not an AACN cutoff

No single laboratory number equals neuronal injury. Duration, recurrence, alternative fuels, and the infant's ability to signal distress all matter. That is why professional statements speak in operational language: values at which you treat and evaluate, not a metaphysical bright line.

AAP Committee on Fetus and Newborn materials have long described treating symptomatic infants and using values near 40 mg/dL in the earliest hours and nearer 45 mg/dL after about four hours for asymptomatic at-risk newborns. PES guidance has used less than 50 mg/dL in the first 48 hours as a threshold that should prompt treatment and investigation in at-risk or symptomatic infants, with a higher therapeutic goal (discussion often cites the 60-70 mg/dL range) when hypoglycemia persists beyond 48 hours. Those documents are nursery guidance; they are not a CCRN answer key.

Unit protocols vary. Follow the written protocol in the unit where you are standing. Do not invent a fake AACN official number. The Neonatal CCRN Test Plan names glucose homeostasis as a patient problem. It does not assign a milligram-per-deciliter cutoff. Exam items typically test whether you treat symptoms, start dextrose correctly, calculate GIR, and recognize hyperinsulinism.

After 48 hours, a baby who still needs IV dextrose to stay euglycemic is no longer in the first-hour operational conversation. That infant needs a cause: hyperinsulinism, hormone deficiency, or a metabolic disorder (section 6.3).

D10W 2 mL/kg, then an infusion

The neonatal mini-bolus is D10W 2 mL/kg intravenously, which delivers 200 mg/kg of dextrose. D25W and D50W belong in older children and crash-cart folklore, not in a 3 kg peripheral vein. Concentrated dextrose is hyperosmolar, injures intima, and can provoke a sharp insulin release that rebounds the glucose downward.

Give the mini-bolus and start a continuous infusion immediately. Recheck in about 15-30 minutes. A bolus without a drip is a common setup for a second crash. If there is no IV yet, dextrose gel plus a feed is used in many well-baby pathways; a seizing, apneic, or critically ill neonate needs intravenous glucose now.

Enteral milk is the physiologic fuel. Intravenous dextrose is a bridge. When feeding is established and values are stable, wean the infusion; do not clamp it off.

Glucose infusion rate

Term hepatic production is about 4-6 mg/kg/min. Preterm infants often need the high end of typical support. Start near 4-8 mg/kg/min. A requirement above about 10-12 mg/kg/min to maintain euglycemia is a hyperinsulinism flag.

Commit one formula:

GIR (mg/kg/min) = (percent dextrose x infusion rate in mL/kg/day) / 144

Equivalent shortcuts: GIR = (percent dextrose x mL/kg/hour) / 6, or percent dextrose x mL/kg/hour x 0.167.

If a 2.5 kg infant on D10W at 100 mL/kg/day is still hypoglycemic, raising to D12.5 at the same rate increases GIR from 6.9 to 8.7. If that is not enough, raise concentration (central access generally for more than D12.5) or rate (watch fluid overload) or both. Hyperinsulinism may need D15-D20 and a GIR of 12-20 plus endocrine consultation, a diagnostic critical sample drawn when glucose is low, glucagon, and sometimes diazoxide. Those drugs are specialist decisions. The CCRN-level action is recognizing a high GIR need and not answering the problem with another isolated bolus. Peripheral D12.5 already carries infiltration risk; hypertonic dextrose in a scalp or hand IV can destroy tissue.

When glucose is low, the critical sample (insulin, C-peptide, beta-hydroxybutyrate, free fatty acids, cortisol, growth hormone, lactate, and ammonia as indicated) is worth more than a later guess. High insulin with suppressed ketones during hypoglycemia is the biochemical signature of hyperinsulinism.

Infant of a diabetic mother: glucose physiology here

Maternal hyperglycemia—pregestational or gestational, especially if glucose was high in the third trimester—drives fetal hyperglycemia. The fetal pancreas hypersecretes insulin and beta-cell mass increases. Insulin is anabolic, which is why macrosomia happens. After birth the placental glucose supply stops, but insulin does not fall on cue. The infant has hyperinsulinemic hypoglycemia: high peripheral uptake, locked glycogenolysis, locked gluconeogenesis, and suppressed ketogenesis. The brain sees low glucose without ketone backup. Hypoglycemia is often earliest in the first hours and may recur for 24-72 hours, occasionally longer if maternal control was poor.

This section owns that mechanism. IDM is also Multisystem problem MU-9. Polycythemia, RDS from delayed surfactant, birth trauma from macrosomia, hypocalcemia, and hypertrophic cardiomyopathy are taught in the later Infant of a Diabetic Mother chapter (Chapter 13). Preview them so the phenotype makes sense; do not try to manage the whole IDM list from a glucose-only question. The thread that ties the phenotype together is still hyperinsulinism.

Hyperglycemia in ELBW, sepsis, and steroids

High glucose in the NICU is usually iatrogenic or stress-related, not neonatal diabetes. Extremely low-birth-weight infants have immature insulin responses and often receive a high GIR in parenteral nutrition. Sepsis and shock release catecholamines and cortisol, producing insulin resistance. Dexamethasone or hydrocortisone raise glucose. Confirm with a laboratory value. Consequences include osmotic diuresis, dehydration, and a higher infection risk. Lower GIR toward 4-8 mg/kg/min when nutrition allows. Insulin infusion is reserved for selected ELBW infants with persistent marked hyperglycemia and requires frequent glucose checks. A new hyperglycemia in a previously stable infant is a sepsis clue until proven otherwise.

Bedside sequence

1. Identify at-risk or symptomatic infants.
2. Measure glucose; confirm borderline point-of-care results.
3. Feed if appropriate; give D10W 2 mL/kg when IV treatment is indicated.
4. Start GIR 4-8 mg/kg/min; go higher when hyperinsulinism is likely.
5. Recheck, titrate, and search for cause.
6. Persistent or high-GIR hypoglycemia needs endocrine evaluation, not endless mini-boluses.

Practice application of these decisions at /practice/ccrn-neonatal.